AVIEW LCS vs Eko Analysis Software
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your practice requires a comprehensive, AI-powered solution for the automated analysis of low-dose CT scans. This tool is ideal for radiology departments and lung cancer screening programs needing precise lung nodule detection, Lung-RADS classification, and integrated assessment of COPD and coronary artery calcification. It streamlines workflows by providing automated reports and comparison capabilities for follow-up scans.
View AVIEW LCS →Choose Eko Analysis Software if…
Choose Eko Analysis Software if you need an accessible, AI-powered tool for the early detection of cardiovascular diseases during routine physical examinations or remote patient monitoring. This software, integrated with digital stethoscopes, is best suited for clinicians in primary care, emergency medicine, or telehealth who require immediate AI-assisted insights into heart murmurs and atrial fibrillation. It enables easy recording, playback, and secure storage of heart sounds and ECGs at the point of care.
View Eko Analysis Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | Eko Analysis Software |
|---|---|---|
| Pricing | Contact for pricing | Freemium with subscription for full features |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareWhile AVIEW LCS streamlines complex radiology workflows through PACS/RIS integration and automated reporting, Eko Analysis Software offers more immediate and accessible usability. Its integration with a mobile app and digital stethoscope provides intuitive, real-time point-of-care diagnostics for a broader range of clinicians, further enhanced by a freemium model for easy adoption.
Clinical Value
AVIEW LCSAVIEW LCS offers a broader and more comprehensive clinical impact by providing integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. This multi-disease assessment enhances diagnostic accuracy and provides significant value per patient encounter.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software clearly wins on pricing transparency and accessibility with its freemium model and tiered subscription options for full features. This allows users to start with basic functionalities for free and scale up, offering flexible value, whereas AVIEW LCS requires contacting for pricing, suggesting a higher, enterprise-level investment.
Enterprise Readiness
AVIEW LCSAVIEW LCS demonstrates superior enterprise readiness through its diverse deployment options, including cloud, hybrid, local hardware, and virtualized solutions. Its explicit integration capabilities with PACS/RIS and other third-party platforms are crucial for seamless adoption within large and complex healthcare IT infrastructures.
Innovation
TieBoth tools showcase significant innovation in their respective fields. AVIEW LCS innovates by providing integrated multi-disease analysis from a single CT scan, optimizing radiology workflows. Eko Analysis Software is equally innovative by integrating AI with a traditional diagnostic tool (stethoscope) for real-time, point-of-care detection of cardiovascular conditions, democratizing advanced diagnostics.
Support & Docs
Eko Analysis SoftwareEko Analysis Software offers a more transparent and comprehensive support ecosystem, including a dedicated Help Center with user manuals and FAQs, multiple direct contact channels (email, phone, chat), and documented extended support hours. Coreline Soft provides contact information and offers consultations, but Eko's resources appear more extensive and readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | Eko Analysis Software |
|---|---|---|
| Name | AVIEW LCS | Eko Analysis Software |
| Company | Coreline Soft Co. | Eko Devices |
| Tagline | AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment | Your new partner in precise, proactive heart and lung care. |
| Primary Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features (Examples) | Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and Eko Analysis Software.